GNH USA

Europe — EMA

Mst Continus (Morphine Sulfate)

GNH USA supplies Mst Continus (Morphine Sulfate), an opioid analgesic for moderate to severe pain, including cancer and chronic pain.

Request sourcing

1
Pack/s

What is Morphine Sulfate?

Morphine Sulfate, the active ingredient in Mst Continus, is an opioid analgesic presented as an oral formulation for oral use. It is employed to manage moderate to severe pain, including chronic non‑cancer pain, cancer‑related pain, and postoperative pain in adult patients. It is indicated for use under strict medical supervision.

GNH USA supplies Mst Continus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support safe distribution across global markets.

What is Morphine Sulfate used for?

Morphine Sulfate is an opioid analgesic used to treat pain conditions. - Severe acute pain: provides rapid analgesia for postoperative or trauma‑related pain. - Chronic cancer pain: helps control persistent pain associated with malignant disease. - Chronic non‑cancer pain: used when other analgesics are insufficient.

What are the side effects of Morphine Sulfate?

Common Side Effects: - Nausea: feeling of sickness often accompanied by an urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or fatigue. - Dizziness: sensation of light‑headedness or unsteadiness. - Vomiting: expulsion of stomach contents.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe allergic reaction: rash, itching, swelling, or anaphylaxis. - Hypotension: marked drop in blood pressure causing dizziness or fainting.

What precautions apply to Morphine Sulfate?

Morphine sulfate requires careful clinical oversight due to its potency and risk profile. - Dose titration: adjust dose gradually to balance pain relief and side effects. - Risk of dependence: monitor for signs of misuse or addiction. - Respiratory status: assess breathing function before initiating therapy. - Concurrent CNS depressants: avoid or use with caution. - Renal/hepatic impairment: consider dose reduction. - Store at ambient temperature: keep in original container, protect from moisture and light.

What does Morphine Sulfate interact with?

Morphine sulfate can interact with several medication classes. Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines): may cause profound sedation and respiratory depression. - MAO inhibitors: risk of severe hypertension or serotonin syndrome. Moderate Interactions (Monitor Closely): - Anticholinergics: may worsen constipation. - Diuretics: may increase hypotension. - Selective serotonin reuptake inhibitors: may increase risk of serotonin syndrome.

Frequently asked questions

What is Mst Continus used for?+
Mst Continus contains morphine sulfate, an opioid analgesic prescribed for the management of moderate to severe pain. It is commonly used in patients with chronic cancer pain, severe postoperative pain, and other persistent pain conditions where non‑opioid therapies have not provided adequate relief.
How does morphine sulfate work?+
Morphine sulfate binds to mu‑opioid receptors in the brain and spinal cord, activating inhibitory pathways that reduce the transmission of pain signals. This receptor activation leads to decreased neuronal excitability and a higher pain threshold, providing effective analgesia.
What is the usual dose of Mst Continus?+
The appropriate dose of Mst Continus is individualized and determined by the prescribing clinician based on the patient’s pain severity, prior opioid exposure, and overall health status. Dosage adjustments are made to achieve adequate pain control while minimizing adverse effects.
Is Mst Continus safe in pregnancy or breastfeeding?+
Safety data for morphine sulfate during pregnancy and lactation are limited. It is generally contraindicated in pregnant women unless the potential benefit outweighs the risk to the fetus. Morphine can pass into breast milk, so breastfeeding is usually discouraged while using this medication.
How do I order Mst Continus from GNH USA?+
To order Mst Continus, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Mst Continus compare with other opioid analgesics?+
Morphine sulfate is considered a benchmark opioid with well‑characterized efficacy and safety. Compared with alternatives such as oxycodone or hydromorphone, morphine has a longer history of use and a predictable conversion ratio, but individual response and side‑effect profiles may vary, making clinician judgment essential.
What are the storage and handling requirements for Mst Continus?+
Mst Continus should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure it is out of reach of children and unauthorized personnel.
How is Mst Continus administered?+
Mst Continus is intended for oral administration. The tablet (or oral formulation) should be swallowed whole with a full glass of water. It should not be crushed, chewed, or dissolved unless specifically directed by a healthcare professional.
What are the most serious risks associated with Mst Continus?+
The most serious risks include respiratory depression, which can be life‑threatening, especially in opioid‑naïve patients or when combined with other depressants. Additional concerns are severe hypotension, profound sedation, dependence, and the potential for overdose.
Who should not use Mst Continus?+
Mst Continus is contraindicated in patients with significant respiratory depression, acute or severe asthma, paralytic ileus, known hypersensitivity to morphine or other opioids, and in individuals taking monoamine oxidase inhibitors within 14 days. Clinicians should evaluate each patient’s medical history before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Morphine Sulfate
Route
Oral Use
Manufacturer
Mundipharma Pharmaceuticals Limited
Origin
EU

Related products